Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Fatty Acyls [FA]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA01070055 EHHDA 11,12-epoxy-10-hydroxy-8E-heptadecenoic acid FA 17:2;O2 C17H30O4 298.214411
LMFA01060259 12-oxo-8E,10E-heptadecadienoic acid FA 17:3;O C17H28O3 280.203846
LMFA01060259 12-oxo-8E,10E-heptadecadienoic acid FA 17:3;O C17H28O3 280.203846
LMFA03050042 11,12-dihydroxy-19-oxo-5Z,8Z,14Z-eicosatrienonic acid FA 20:4;O3 C20H32O5 352.224976
LMFA03050042 11,12-dihydroxy-19-oxo-5Z,8Z,14Z-eicosatrienonic acid FA 20:4;O3 C20H32O5 352.224976
LMFA03050042 11,12-dihydroxy-19-oxo-5Z,8Z,14Z-eicosatrienonic acid FA 20:4;O3 C20H32O5 352.224976
LMFA03050042 11,12-dihydroxy-19-oxo-5Z,8Z,14Z-eicosatrienonic acid FA 20:4;O3 C20H32O5 352.224976
LMFA08040039 20-HETE-EA N-(20-hydroxy-5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine NAE 20:4;O C22H37NO3 363.277344
LMFA08040039 20-HETE-EA N-(20-hydroxy-5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine NAE 20:4;O C22H37NO3 363.277344
LMFA08040039 20-HETE-EA N-(20-hydroxy-5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine NAE 20:4;O C22H37NO3 363.277344
LMFA01030834 32:5(17Z,20Z,23Z,26Z,29Z) 17Z,20Z,23Z,26Z,29Z-dotriacontapentaenoic acid FA 32:5 C32H54O2 470.412381
LMFA11000457 5-Methylheneicosane 5-Methylheneicosane C22H46 310.359951
LMFA03010302 15-oxo-13,14-dihydro-2,3,4,5,18,19-hexanor-PGF2alpha 9S,11R,15S,19R-tetrahydroxy-2,3,4,5,18,19-hexanor-prosta-1,20-dioic acid FA 14:3;O5 C14H22O7 302.136555
LMFA03010302 15-oxo-13,14-dihydro-2,3,4,5,18,19-hexanor-PGF2alpha 9S,11R,15S,19R-tetrahydroxy-2,3,4,5,18,19-hexanor-prosta-1,20-dioic acid FA 14:3;O5 C14H22O7 302.136555
LMFA03010302 15-oxo-13,14-dihydro-2,3,4,5,18,19-hexanor-PGF2alpha 9S,11R,15S,19R-tetrahydroxy-2,3,4,5,18,19-hexanor-prosta-1,20-dioic acid FA 14:3;O5 C14H22O7 302.136555
LMFA03010302 15-oxo-13,14-dihydro-2,3,4,5,18,19-hexanor-PGF2alpha 9S,11R,15S,19R-tetrahydroxy-2,3,4,5,18,19-hexanor-prosta-1,20-dioic acid FA 14:3;O5 C14H22O7 302.136555
LMFA07010200 SFE 9:0/2:0 Nonyl acetate SFE 11:0 C11H22O2 186.161980
LMFA08040040 15-HETE-EA N-(15-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoyl)-ethanolamine NAE 20:4;O C22H37NO3 363.277344
LMFA08040040 15-HETE-EA N-(15-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoyl)-ethanolamine NAE 20:4;O C22H37NO3 363.277344
LMFA08040040 15-HETE-EA N-(15-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoyl)-ethanolamine NAE 20:4;O C22H37NO3 363.277344
LMFA07010220 SFE 11:0/2:0 Undecyl acetate SFE 13:0 C13H26O2 214.193280
LMFA01050614 8,11,12-trihydroxy-9-heptadecenoic acid FA 17:1;O3 C17H32O5 316.224976
LMFA01050614 8,11,12-trihydroxy-9-heptadecenoic acid FA 17:1;O3 C17H32O5 316.224976
LMFA03010303 20-hydroxy-15-oxo-13,14-dihydro-2,3,4,5-tetranor-PGF2alpha 9S,11R,20-trihydroxy-2,3,4,5-tetranor-prosta-1,20-dioic acid FA 16:2;O4 C16H28O6 316.188591
LMFA03010303 20-hydroxy-15-oxo-13,14-dihydro-2,3,4,5-tetranor-PGF2alpha 9S,11R,20-trihydroxy-2,3,4,5-tetranor-prosta-1,20-dioic acid FA 16:2;O4 C16H28O6 316.188591
LMFA03010303 20-hydroxy-15-oxo-13,14-dihydro-2,3,4,5-tetranor-PGF2alpha 9S,11R,20-trihydroxy-2,3,4,5-tetranor-prosta-1,20-dioic acid FA 16:2;O4 C16H28O6 316.188591
LMFA03010303 20-hydroxy-15-oxo-13,14-dihydro-2,3,4,5-tetranor-PGF2alpha 9S,11R,20-trihydroxy-2,3,4,5-tetranor-prosta-1,20-dioic acid FA 16:2;O4 C16H28O6 316.188591
LMFA03100027 ent-12-iso-LGD2 (5R,9S)-6,7-seco-6,8-dioxo-12R-hydroxy-10E,14Z-prostadienoic acid FA 20:4;O3 C20H32O5 352.224976
LMFA03100027 ent-12-iso-LGD2 (5R,9S)-6,7-seco-6,8-dioxo-12R-hydroxy-10E,14Z-prostadienoic acid FA 20:4;O3 C20H32O5 352.224976
LMFA03100027 ent-12-iso-LGD2 (5R,9S)-6,7-seco-6,8-dioxo-12R-hydroxy-10E,14Z-prostadienoic acid FA 20:4;O3 C20H32O5 352.224976
LMFA03100027 ent-12-iso-LGD2 (5R,9S)-6,7-seco-6,8-dioxo-12R-hydroxy-10E,14Z-prostadienoic acid FA 20:4;O3 C20H32O5 352.224976
LMFA01030871 20:4(5Z,13Z,16Z,19Z) 5Z,13Z,16Z,19Z-eicosatetraenoic acid FA 20:4 C20H32O2 304.240231
LMFA01030811 4Z,7Z,10Z,13Z,16Z,19Z,22Z,25Z-octacosaoctaenoic acid 4Z,7Z,10Z,13Z,16Z,19Z,22Z,25Z-octacosaoctaenoic acid FA 28:8 C28H40O2 408.302831
LMFA03110099 15-D2t-IsoP 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid-cyclo[8S,12R] FA 20:4;O3 C20H32O5 352.224976
LMFA05000133 6E-Nonen-1-ol 6E-Nonen-1-ol FOH 9:1 C9H18O 142.135765
LMFA07010392 SFE 18:2(2Z,13Z)/2:0 2Z,13Z-Octadecadienyl acetate SFE 20:2 C20H36O2 308.271531
LMFA03110063 ent-8-deoxy-J2-IsoP 14-oxo-5Z,8E,10E,12-prostatetraenoic acid-cyclo[11,15R] FA 20:6;O C20H28O3 316.203846
LMFA01020310 Mycocerosic acid (C26) 2R,4R-dimethyl-tetracosanoic acid FA 26:0 C26H52O2 396.396731
LMFA08020088 N-oleoyl glutamic acid N-(9Z-octadecenoyl)-glutamic acid NAGlu 18:1 C23H41NO5 411.298474
LMFA08020088 N-oleoyl glutamic acid N-(9Z-octadecenoyl)-glutamic acid NAGlu 18:1 C23H41NO5 411.298474
LMFA07010391 SFE 18:2(3Z,13E)/2:0 3Z,13E-Octadecadienyl acetate SFE 20:2 C20H36O2 308.271531
LMFA07010391 SFE 18:2(3Z,13E)/2:0 3Z,13E-Octadecadienyl acetate SFE 20:2 C20H36O2 308.271531
LMFA03010292 20-hydroxy-13,14-dihydro 2,3,4,5-tetranor- PGF2alpha 9S,11R,15S,20-tetrahydroxy-5Z-2,3,4,5-tetranor-prostenoic acid FA 16:1;O4 C16H30O6 318.204241
LMFA03010304 19-hydroxy-15-oxo-13,14-dihydro-2,3,4,5-tetranor-PGF2alpha 9S,11R,19-trihydroxy-2,3,4,5-tetranor-prosta-1,20-dioic acid FA 16:2;O4 C16H28O6 316.188591
LMFA03010304 19-hydroxy-15-oxo-13,14-dihydro-2,3,4,5-tetranor-PGF2alpha 9S,11R,19-trihydroxy-2,3,4,5-tetranor-prosta-1,20-dioic acid FA 16:2;O4 C16H28O6 316.188591
LMFA03010304 19-hydroxy-15-oxo-13,14-dihydro-2,3,4,5-tetranor-PGF2alpha 9S,11R,19-trihydroxy-2,3,4,5-tetranor-prosta-1,20-dioic acid FA 16:2;O4 C16H28O6 316.188591
LMFA03010304 19-hydroxy-15-oxo-13,14-dihydro-2,3,4,5-tetranor-PGF2alpha 9S,11R,19-trihydroxy-2,3,4,5-tetranor-prosta-1,20-dioic acid FA 16:2;O4 C16H28O6 316.188591
LMFA03010305 15-oxo-13,14-dihydro-2,3,4,5-tetranor-PGF2alpha 9S,11R,dihydroxy-2,3,4,5-tetranor-prosta-1,20-dioic acid FA 16:2;O3 C16H28O5 300.193676
LMFA03010305 15-oxo-13,14-dihydro-2,3,4,5-tetranor-PGF2alpha 9S,11R,dihydroxy-2,3,4,5-tetranor-prosta-1,20-dioic acid FA 16:2;O3 C16H28O5 300.193676
LMFA03010305 15-oxo-13,14-dihydro-2,3,4,5-tetranor-PGF2alpha 9S,11R,dihydroxy-2,3,4,5-tetranor-prosta-1,20-dioic acid FA 16:2;O3 C16H28O5 300.193676